| Ms Deborah Myers, MA, CCC-SLP | |
|
3250 Spruce Ave, Bremerton, WA 98310-3554 | |
| (360) 473-4580 | |
| (360) 473-1043 |
| Full Name | Ms Deborah Myers |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3250 Spruce Ave, Bremerton, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457755936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 12159877 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Deborah Myers, MA, CCC-SLP 134 Marion Ave N, Bremerton, WA 98312-3542 Ph: (360) 473-4580 | Ms Deborah Myers, MA, CCC-SLP 3250 Spruce Ave, Bremerton, WA 98310-3554 Ph: (360) 473-4580 |
News Archive
Human Genome Sciences, Inc. today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) relating to the Company's Biologics License Application (BLA) requesting the approval of raxibacumab for use in the treatment of inhalational anthrax. The FDA issues Complete Response Letters to request additional information needed to complete the review of a BLA.
A simulation model of different designs of taxes on sugary drinks, which are linked to obesity, cardiovascular disease, and diabetes, suggests that all tax designs would generate substantial health gains as well as lower health costs in the U.S., according to new research published today in the American Heart Association's flagship journal Circulation.
Solasia Pharma K.K. (http://www.solasia.co.jp), a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today the completion of a Phase I clinical trial for SP-01 (extended release transdermal granisetron patch; brand name: Sancuso®) in Japanese volunteers.
Ninety percent of all chemical products require catalysts in the course of their manufacture. They accelerate reactions and reduce the energy needed. Catalysts participate in reactions, but are not consumed. As a result one catalyst molecule can convert millions of substrate molecules, which explains the great economic value of catalysts.
› Verified 9 days ago
Mrs. Carissa Noel Fletcher, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5112 Nw Taylor Rd, Bremerton, WA 98312 Phone: 360-373-2536 Fax: 360-373-4934 | |
Elizabeth Ann Hupp, BS/MSPA CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5112 Nw Taylor Rd, Bremerton, WA 98312 Phone: 360-373-2536 | |
Allyson Mary Vaccaro-pelton, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2378 Schley Blvd, Bremerton, WA 98310 Phone: 808-462-1001 | |
Julia Laura Gruner, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1097 Ne Sockeye Ct, Bremerton, WA 98311 Phone: 661-400-1864 | |
Ms. Thimberley Nicole Morgan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Ne Foster Rd, Bremerton, WA 98311 Phone: 757-748-5380 | |
Ms. Deborah M. Brewczynski, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5112 Nw Taylor Rd, Bremerton, WA 98312 Phone: 360-373-2536 Fax: 360-373-4934 | |
Ms. Cynthia Marie Wilkins, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 National Ave N, Bremerton, WA 98312 Phone: 360-620-1006 |